|Project Title||Prospective Influenza Vaccine Safety Surveillance using Fresh Data in the Sentinel System|
Sunday, May 1, 2016
The Sentinel System can implement a sequential analysis system that uses fresh data for medical product safety surveillance. Active surveillance using sequential analysis of fresh data holds promise for detecting clinically significant health risks early. Limitations of employing fresh data for surveillance include cost and the need for careful scrutiny of signals.
|Population / Cohort||
- Vaccines, Blood & Biologics
- Devices and Radiologic Health